Saponins Effect on Human Insulin Amyloid Aggregation

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Protein misfolding and amyloid aggregation are implicated in neurodegenerative diseases.
• Intermediate oligomeric species and insoluble aggregates alter the extracellular environment.
• Research seeks cosolvents and cosolutes to inhibit amyloid aggregation.

Purpose of the Study:

• To investigate the effect of saponins on human insulin aggregation.
• To understand the mechanism of saponin-insulin interaction.
• To explore saponins as potential amyloid inhibitors.

Main Methods:

• Fluorescence and UV-Visible spectroscopies with Thioflavin T and Congo Red probes.
• Circular Dichroism for secondary structure changes.
• Synchrotron Small-Angle X-ray Scattering and Dynamic Light Scattering for aggregate structure and size.
• Atomic Force Microscopy for aggregate morphology.
• Molecular Dynamics simulations for interaction analysis.

Main Results:

• Saponins strongly inhibit the formation of insulin fibrils.
• A dose-dependent inhibitory effect was observed.
• Inhibition is significant even at low saponin concentrations (0.01% w/w).
• Saponins likely interact specifically with insulin monomers.

Conclusions:

• Saponins are effective inhibitors of human insulin amyloid aggregation.
• Saponins show promise as natural amyloid inhibitors and stabilizing agents.
• This research may lead to new strategies for managing insulin amyloidosis.